M-GAM2: Key Enzyme in Glycation Process (G93432)

Target Name: MGAM2

NCBI ID: G93432

M-GAM2: Key Enzyme in Glycation Process

Maltase-glucoamylase 2 (M-GAM2) is a protein that is expressed in various tissues throughout the body, including the pancreas, small intestine, and muscle. It is a key enzyme in the glycation process, which involves the covalent binding of glucose to proteins. M-GAM2 is primarily localized to the endoplasmic reticulum (ER), where it is involved in the sorting of glucose-containing proteins for degradation.

M-GAM2 is a member of the glycylating enzyme family 11 (GEF-11), which includes a diverse group of enzymes that are involved in the regulation of cellular processes such as cell growth, differentiation, and inflammation. M-GAM2 is unique in that it is a type of GEF-11 enzyme that is involved in the glycation of proteins, rather than in the regulation of their levels.

The glycation process is a well-known phenomenon that is involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. During glycation, glucose covalently binds to various proteins, resulting in changes in their structure, stability, and function. The covalent binding of glucose to proteins can also affect their stability and contribute to the development of various diseases, including diabetes.

M-GAM2 is involved in the sorting of glucose-containing proteins for degradation in the ER. It helps to ensure that only glucose-containing proteins that are essential for cellular function are retained in the ER and kept out of the cytoplasm, where they can contribute to the development of various diseases.

M-GAM2 is also involved in the regulation of cellular processes such as cell growth and differentiation. It has been shown to play a role in the regulation of pancreatic cancer cell growth and has also been shown to be involved in the regulation of muscle cell proliferation.

M-GAM2 is also involved in the regulation of inflammation. It has been shown to play a role in the regulation of inflammatory responses and has been implicated in the development of various inflammatory diseases.

Due to its involvement in the regulation of cellular processes, M-GAM2 has been considered as a potential drug target. Researchers have been studying the potential therapeutic benefits of targeting M-GAM2 in order to treat various diseases, including diabetes, cancer, and inflammation.

In addition, M-GAM2 has also been identified as a potential biomarker for several diseases, including diabetes and cancer. Its expression has been shown to be altered in various diseases, including type 1 diabetes and colorectal cancer. These findings suggest that M-GAM2 may be a useful diagnostic or therapeutic target for these diseases.

In conclusion, Maltase-glucoamylase 2 (M-GAM2) is a protein that is involved in the regulation of various cellular processes and has been shown to play a role in the development of various diseases. Its potential as a drug target and biomarker make it an attractive target for further research and development in the future.

Protein Name: Maltase-glucoamylase 2 (putative)

More Common Targets